|
Region
|
0.096a
|
|
Southern
|
170 (28.4%)
|
20 (11.8%)
|
150 (88.2%)
|
|
Middle
|
150 (25.1%)
|
20 (13.3%)
|
130 (86.7%)
|
|
East
|
114 (19.1%)
|
8 (7.0%)
|
106 (93.0%)
|
|
North
|
28 (4.7%)
|
0.0
|
28 (100.0%)
|
|
West
|
136 (22.7%)
|
10 (7.4%)
|
126 (92.6%)
|
|
Gender
|
0.720a
|
|
Male
|
214 (35.8%)
|
22 (10.3%)
|
192 (89.7%)
|
|
Female
|
384 (64.2%)
|
36 (9.4%)
|
348 (90.6%)
|
|
Age in years, mean ± SD (range)
|
32.4 ± 8.5 (15–60)
|
33.5 ± 9.9 (15–56)
|
32.3 ± 8.3 (15–60)
|
0.323b
|
|
Marital status
|
0.597a
|
|
Single
|
250 (41.8%)
|
24 (9.6%)
|
226 (90.4%)
|
|
Married
|
310 (51.8%)
|
34 (11.0%)
|
276 (89.0%)
|
|
Divorced
|
36 (6.0%)
|
0.0
|
36 (100.0%)
|
|
Widower
|
2 (0.4%)
|
0.0
|
2 (100.0%)
|
|
Educational level
|
< 0.001a
|
|
Illiterate
|
4 (0.7%)
|
2 (50.0%)
|
2 (50.0%)
|
|
Primary
|
12 (2.0%)
|
2 (16.7%)
|
10 (83.3%)
|
|
Intermediate
|
28 (4.7%)
|
12 (42.9%)
|
16 (57.1%)
|
|
Secondary
|
140 (23.4%)
|
4 (2.9%)
|
136 (97.1%)
|
|
University
|
414 (69.2%)
|
38 (9.2%)
|
376 (90.8%)
|
|
Age at disease onset mean ± SD (range)
|
25.9 ± 7.9 (13–56)
|
27.3 ± 10.4 (14–51)
|
25.7 ± 7.6 (13–56)
|
0.136
|
|
Disease duration in years (mean ± SD)
|
6.6 ± 4.8
|
6.1 ± 4.5
|
6.6 ± 4.8
|
0.476b
|
|
No. of hospital admissions, mean ± SD
|
1.4 ± 1.7
|
1.1 ± 1.4
|
1.4 ± 1.7
|
0.139b
|
|
No. of attacks during last 2 years, mean ± SD (range)
|
1.4 ± 1.9 (0–14)
|
1.5 ± 1.0 (0–4)
|
1.9 ± 2.0 (0–14)
|
0.118b
|
|
Currently used disease-modifying therapiesc
|
0.032a
|
|
Interferon beta-1b (SC)
|
144 (24.1)
|
14 (9.7)
|
130 (90.3)
|
|
Interferon beta-1a (SC)
|
112 (18.7)
|
8 (7.1)
|
104 (92.9)
|
|
Interferon beta-1a (IM)
|
100 (16.7)
|
12 (12.0)
|
88 (88.0)
|
|
Fingolimod (PO)
|
104 (17.4)
|
18 (17.3)
|
86 (82.7)
|
|
Others
|
90 (15.4)
|
4 (4.4)
|
86 (95.6)
|
|
PDDS (mean ± SD)
|
2.8 ± 1.9
|
3.1 ± 2.3
|
2.8 ± 2.00
|
0.219b
|
